Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001209191-21-068135

Chief Operating Officer bought 25,201 shares at $1.38 ($34,777)

From the SEC's structured data for this filing

Trades in this filing

Dagnon Terry · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-12-06 Purchase : show line 1 in the form +25,201 $1.38 $34,777 1,163,058 D
Open-market purchases · 25,201 sh · avg $1.38 · $34,777
Loading xslF345X03/doc4.xml…